GlobeNewswire Inc.··Delveinsight50+ Pharma Giants Race to Transform PAH Treatment With 55+ Pipeline Drugs
Over 50 pharmaceutical companies advance 55+ experimental drugs for pulmonary arterial hypertension, with recent clinical breakthroughs and strategic acquisitions accelerating innovation.
PFEABBVGSKBIIBUTHR+2clinical trialsrare disease